FutureTech II Acquisition Corp.

FutureTech II Acquisition Corp. is a Delaware-incorporated blank check company formed to complete a merger, stock exchange, asset acquisition, or similar business combination. It has no operating business of its own and is focused on identifying and closing a transaction, with the current disclosed target being Longevity Biomedical, Inc.

0.07

0.07

— FutureTech II Acquisition Corp.
%
SPAC formation and listing vehicle0% A publicly traded shell company created to raise capital and pursue a future acquisition.
Business combination execution0% Transaction structuring and closing activities related to a proposed merger or acquisition.
Private placement and financing support0% PIPE-style capital commitments and related financing arrangements tied to the transaction.
Trust account administration0% Management of IPO proceeds held in trust for shareholder redemptions and deal funding.

The company does not sell products or services to end customers in the normal operating sense...

  • Public shareholdersprimary

    Invest in the SPAC for redemption rights and potential upside if a business combination closes.

  • Merger target companyprimary

    The target, currently disclosed as Longevity Biomedical, Inc., is the core counterparty for the business combination.

  • PIPE investorssecondary

    Provide private placement capital to support the merger and post-close capitalization.

  • Warrant holderssecondary

    Hold optionality on the combined company’s equity value after the transaction.

FutureTech II Acquisition Corp. is incorporated in Delaware and operates as a U.S.-based capital markets vehicle...

  • •Incorporated in Delaware, United States
  • •No operating revenue or manufacturing footprint disclosed
  • •Exposure is tied to U.S. capital markets and listing venues
  • •Transaction counterparties may be U.S.-based or international
  • •Geography matters mainly through regulatory and financing access

The company’s strategy is to complete its announced business combination and secure the financing needed to close it...

01
Complete the Longevity Biomedical mergershort-term

The company has no operating business until a transaction closes, so execution is existential.

02
Secure financing supportshort-term

The deal depends on sufficient capital at closing and post-close funding credibility.

03
Preserve public market accessshort-term

Listing status affects redemption dynamics, financing access, and merger completion probability.

The main risk is that the company may fail to complete its business combination, which would leave it without an...

critical

Failure to consummate the business combination

The company is a blank check entity with no operating business, so failure to close would leave it without a commercial platform.

Scope
Longevity Biomedical merger process
Materiality
high
high

Redemptions reduce transaction cash

Shareholder redemptions shrink the trust balance and can make the deal harder to finance.

Scope
228,287 shares tendered for redemption in August 2025
Materiality
high
high

Listing and marketability risk

OTC Pink trading or Nasdaq delisting can reduce liquidity, financing access, and merger credibility.

Scope
Nasdaq listing status and secondary market trading
Materiality
high
medium

Trust account and third-party claim risk

Claims against the trust account could reduce funds otherwise available for redemption or closing.

Scope
Trust account protection and creditor claims
Materiality
medium
Redeemable Class A common stock
Accretion to redemption value and balance sheet presentation
Deferred underwriting commission
Closing-dependent liability and transaction accounting
Accretion to redemption value
Non-cash charge affecting earnings and shareholders' equity
Estimates and assumptions
Reported liabilities and expenses may change materially

Future Vision II Acquisition Corp.

FVN · Services-Computer Integrated Systems Design

FACT II Acquisition Corp.

FACT · Aircraft Parts & Auxiliary Equipment, NEC

FutureCrest Acquisition Corp.

FCRS · Blank Checks

RF Acquisition Corp II

RFAI · Blank Checks

Concord Acquisition Corp II

CNDA · Blank Checks

Inception Growth Acquisition Ltd

Blank Checks

: 28/04/2026